HR4752Referred to Committee

Reducing Hereditary Cancer Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-23
Introduced
29
Cosponsors
HR
ⓘ
Type

Sponsor

Debbie Wasserman Schultz
Debbie Wasserman Schultz
Democrat · FL · Representative
Votes with party: 97.2% (541 recorded votes)

Full profile: /officials/W000797

Source: Congress.gov · FEC

Cosponsors (29)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-07-23

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.